Successful Treatment of Pemphigus Vulgaris With Ofatumumab

Rapp, MB; Pentland, AP; Richardson, CT

Richardson, CT (reprint author), Univ Rochester, Dept Dermatol, Med Ctr, Rochester, NY 14627 USA.

JOURNAL OF DRUGS IN DERMATOLOGY, 2018; 17 (12): 1338

Abstract

Rituximab is a chimeric anti-CD20 monoclonal antibody that is very effective in treating patients with pemphigus vulgaris. Though infrequent, the deve......

Full Text Link